78 In a study by Chen et al ., dextran sulfate-CMs were developed for the efficient delivery of rhBMP-2
First, investigational is not a criticism of the data CagriSemas evidence is large-scale, randomized, and controlled but it does mean there is no approved indication, no approved dose, and no completed regulatory safety determination behind it yet
Given her clinical picture and MRI characteristics this gene mutation is likely pathogenic
When administered by licensed clinicians under medically-supervised protocols, mobile IV therapy is generally considered safe for appropriate candidates
One week is the recovery time
Samples were analyzed on a Thermo-Finnigan Trace DSQ fast-scanning single-quadrupole mass spectrometer using electron impact ionization